Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Breast cancer 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
2 Breast cancer 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
3 Breast cancer 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
4 Breast cancer 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
5 Breast cancer 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
6 Breast cancer 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
7 Breast cancer 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
8 Breast cancer 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
9 Breast cancer 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
10 Breast cancer 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
11 Breast cancer 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
12 Breast cancer 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
13 Calcium signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
14 Calcium signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
15 Calcium signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
16 Calcium signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
17 Calcium signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
18 Calcium signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
19 Calcium signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
20 Calcium signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
21 Calcium signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
22 Calcium signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
23 Calcium signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
24 Calcium signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
25 Focal adhesion 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
26 Focal adhesion 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
27 Focal adhesion 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
28 Focal adhesion 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
29 Focal adhesion 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
30 Focal adhesion 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
31 Focal adhesion 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
32 Focal adhesion 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
33 Focal adhesion 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
34 Focal adhesion 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
35 Focal adhesion 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
36 Focal adhesion 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
37 MAPK signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
38 MAPK signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
39 MAPK signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
40 MAPK signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
41 MAPK signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
42 MAPK signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
43 MAPK signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
44 MAPK signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
45 MAPK signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
46 MAPK signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
47 MAPK signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
48 MAPK signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
49 Pathways in cancer 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
50 Pathways in cancer 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
51 Pathways in cancer 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
52 Pathways in cancer 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
53 Pathways in cancer 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
54 Pathways in cancer 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
55 Pathways in cancer 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
56 Pathways in cancer 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
57 Pathways in cancer 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
58 Pathways in cancer 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
59 Pathways in cancer 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
60 Pathways in cancer 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
61 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
62 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
63 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
64 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
65 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
66 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
67 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
68 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
69 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
70 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
71 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
72 PI3K-Akt signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
73 Rap1 signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
74 Rap1 signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
75 Rap1 signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
76 Rap1 signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
77 Rap1 signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
78 Rap1 signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
79 Rap1 signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
80 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
81 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
82 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
83 Rap1 signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
84 Rap1 signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬
85 Ras signaling pathway 💬
 [1] FLT4 💬 Catequentinib 💬 Anlotinib [1] 85 💬
86 Ras signaling pathway 💬
 [1] FLT4 💬 Axitinib 💬 Axitinib [1] 34 💬
87 Ras signaling pathway 💬
 [1] FLT4 💬 Cediranib 💬 Cediranib [1] 34 💬
88 Ras signaling pathway 💬
 [1] FLT4 💬 Cediranib maleate 💬 Cediranib [1] 34 💬
89 Ras signaling pathway 💬
 [1] FLT4 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
90 Ras signaling pathway 💬
 [1] FLT4 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
91 Ras signaling pathway 💬
 [1] FLT4 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
92 Ras signaling pathway 💬
 [1] FLT4 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
93 Ras signaling pathway 💬
 [1] FLT4 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
94 Ras signaling pathway 💬
 [1] FLT4 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
95 Ras signaling pathway 💬
 [1] FLT4 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
96 Ras signaling pathway 💬
 [1] FLT4 💬 Tesevatinib 💬 Tesevatinib [1] 67 💬

Back to top